Financials Radient Technologies Inc.

Equities

RTI.H

CA75034P1062

Pharmaceuticals

Delayed Toronto S.E. 03:56:03 2023-03-07 pm EST 5-day change 1st Jan Change
0.005 CAD -.--% Intraday chart for Radient Technologies Inc. -.--% -.--%

Valuation

Fiscal Period: März 2017 2018 2019 2020 2021 2022
Capitalization 1 99.37 328.9 270.9 48.56 42.32 29.2
Enterprise Value (EV) 1 94.28 309.4 245.8 63.42 53.76 42.87
P/E ratio -13.1 x -19.7 x -9.22 x -1.27 x -0.85 x -1.93 x
Yield - - - - - -
Capitalization / Revenue 339 x 722 x 1,265 x 2.64 x 17 x 8.06 x
EV / Revenue 321 x 679 x 1,148 x 3.45 x 21.6 x 11.8 x
EV / EBITDA -26.2 x -23.6 x -9.18 x -2.13 x -2.74 x -8.57 x
EV / FCF -14.1 x -86.7 x -14.2 x -4.08 x -10.2 x -124 x
FCF Yield -7.11% -1.15% -7.05% -24.5% -9.79% -0.8%
Price to Book 22.6 x 12.8 x 5.39 x 2.55 x -18.8 x -2.88 x
Nbr of stocks (in thousands) 150,558 223,738 265,551 277,486 384,746 530,868
Reference price 2 0.6600 1.470 1.020 0.1750 0.1100 0.0550
Announcement Date 7/26/17 7/24/18 7/8/19 9/14/20 10/1/21 9/30/22
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2017 2018 2019 2020 2021 2022
Net sales 1 0.2934 0.4558 0.2141 18.4 2.489 3.622
EBITDA 1 -3.598 -13.09 -26.77 -29.82 -19.61 -5.001
EBIT 1 -4.054 -13.63 -27.88 -31.61 -21.29 -6.454
Operating Margin -1,381.43% -2,990.46% -13,024.89% -171.78% -855.38% -178.2%
Earnings before Tax (EBT) 1 -4.316 -14.05 -27.86 -37.42 -42.27 -12.93
Net income 1 -4.316 -14.05 -27.86 -37.42 -42.27 -12.93
Net margin -1,470.89% -3,081.94% -13,012.97% -203.31% -1,697.84% -357.01%
EPS 2 -0.0503 -0.0745 -0.1106 -0.1375 -0.1299 -0.0286
Free Cash Flow 1 -6.701 -3.569 -17.33 -15.53 -5.263 -0.3446
FCF margin -2,283.55% -782.99% -8,097.93% -84.36% -211.44% -9.51%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 7/26/17 7/24/18 7/8/19 9/14/20 10/1/21 9/30/22
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: March 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - 14.9 11.4 13.7
Net Cash position 1 5.09 19.5 25.1 - - -
Leverage (Debt/EBITDA) - - - -0.4985 x -0.5835 x -2.734 x
Free Cash Flow 1 -6.7 -3.57 -17.3 -15.5 -5.26 -0.34
ROE (net income / shareholders' equity) 493% -92.8% -72.6% -107% -513% 204%
ROA (Net income/ Total Assets) -24.9% -37.8% -38.3% -33.2% -30.5% -14.1%
Assets 1 17.33 37.2 72.76 112.6 138.5 91.4
Book Value Per Share 2 0.0300 0.1200 0.1900 0.0700 -0.0100 -0.0200
Cash Flow per Share 2 0.0600 0.1000 0.1200 0 0 0
Capex 1 0.01 1.25 12.3 11.1 0.12 1.58
Capex / Sales 2.2% 274.82% 5,744.2% 60.13% 4.81% 43.58%
Announcement Date 7/26/17 7/24/18 7/8/19 9/14/20 10/1/21 9/30/22
1CAD in Million2CAD
Estimates
  1. Stock Market
  2. Equities
  3. RTI.H Stock
  4. Financials Radient Technologies Inc.